Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.

Pauly V, Frauger E, Pradel V, Rouby F, Berbis J, Natali F, Reggio P, Coudert H, Micallef J, Thirion X.

Drug Alcohol Depend. 2011 Jan 1;113(1):29-36. doi: 10.1016/j.drugalcdep.2010.06.016.

PMID:
20692778
2.

Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.

Pradel V, Thirion X, Ronfle E, Masut A, Micallef J, Bégaud B.

Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):473-81.

PMID:
15269931
3.

Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine.

Pradel V, Frauger E, Thirion X, Ronfle E, Lapierre V, Masut A, Coudert C, Blin O, Micallef J.

Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):36-43. doi: 10.1002/pds.1681.

PMID:
19040199
4.

Doctor shopping reveals geographical variations in opioid abuse.

Nordmann S, Pradel V, Lapeyre-Mestre M, Frauger E, Pauly V, Thirion X, Mallaret M, Jouanjus E, Micallef J.

Pain Physician. 2013 Jan;16(1):89-100.

5.

Assessment of abuse of tianeptine from a reimbursement database using 'doctor-shopping' as an indicator.

Rouby F, Pradel V, Frauger E, Pauly V, Natali F, Reggio P, Thirion X, Micallef J.

Fundam Clin Pharmacol. 2012 Apr;26(2):286-94. doi: 10.1111/j.1472-8206.2010.00906.x.

PMID:
21210844
6.

Introduction of low dose transdermal buprenorphine -- did it influence use of potentially addictive drugs in chronic non-malignant pain patients?

Skurtveit S, Furu K, Kaasa S, Borchgrevink PC.

Eur J Pain. 2009 Oct;13(9):949-53. doi: 10.1016/j.ejpain.2008.11.005.

PMID:
19095476
7.

[Prescription of high dose buprenorphine by general practitioners].

Feroni I, Paraponaris A, Aubisson S, Bouhnik A, Masut A, Ronfle E, Coudert C, Mabriez JC; et le groupe Bupré MG 13..

Rev Epidemiol Sante Publique. 2004 Dec;52(6):511-22. French.

PMID:
15741914
8.

Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicator.

Pradel V, Delga C, Rouby F, Micallef J, Lapeyre-Mestre M.

CNS Drugs. 2010 Jul;24(7):611-20. doi: 10.2165/11531570-000000000-00000.

PMID:
20527997
9.

Buprenorphine prescription by general practitioners in a French region.

Thirion X, Lapierre V, Micallef J, Ronflé E, Masut A, Pradel V, Coudert C, Mabriez JC, Sanmarco JL.

Drug Alcohol Depend. 2002 Jan 1;65(2):197-204.

PMID:
11772481
10.

Evidence of clonazepam abuse liability: results of the tools developed by the French Centers for Evaluation and Information on Pharmacodependence (CEIP) network.

Frauger E, Pauly V, Pradel V, Rouby F, Arditti J, Thirion X, Lapeyre Mestre M, Micallef J.

Fundam Clin Pharmacol. 2011 Oct;25(5):633-41. doi: 10.1111/j.1472-8206.2010.00882.x.

PMID:
21077937
11.

Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.

Pauly V, Pradel V, Pourcel L, Nordmann S, Frauger E, Lapeyre-Mestre M, Micallef J, Thirion X.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):13-20. doi: 10.1016/j.drugalcdep.2012.03.009.

PMID:
22475815
12.

Is the DEA's new "prescription series" regulation balanced?

Gilson AM, Joranson DE.

J Pain Palliat Care Pharmacother. 2008;22(3):218-20.

PMID:
19042852
13.

Estimation of clonazepam abuse liability: a new method using a reimbursed drug database.

Frauger E, Pauly V, Thirion X, Natali F, Pradel V, Reggio P, Rouby F, Coudert H, Micallef J.

Int Clin Psychopharmacol. 2009 Nov;24(6):318-24. doi: 10.1097/YIC.0b013e328330ae4b.

PMID:
19820405
14.

Doctor and pharmacy shopping for controlled substances.

Peirce GL, Smith MJ, Abate MA, Halverson J.

Med Care. 2012 Jun;50(6):494-500. doi: 10.1097/MLR.0b013e31824ebd81.

PMID:
22410408
15.

The Minnesota Prescription Monitoring Program.

Herman C.

Northwest Dent. 2011 Mar-Apr;90(2):33-5.

PMID:
21667591
16.

Rx drug safety in TN: some successes, some challenges.

Williams B.

Tenn Med. 2009 Apr;102(4):21-3, 26-7. No abstract available.

PMID:
19385365
17.

French general practitioners' attitudes and prescription patterns toward buprenorphine maintenance treatment: does doctor shopping reflect buprenorphine misuse?

Feroni I, Peretti-Watel P, Paraponaris A, Masut A, Ronfle E, Mabriez JC, Obadia Y.

J Addict Dis. 2005;24(3):7-22.

PMID:
16186080
18.

[Regular prescription of narcotics and sedatives to drug-addicted patients in general practice].

Andersen HT.

Tidsskr Nor Laegeforen. 2002 May 10;122(12):1202-4. Norwegian.

19.

Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.

Cicero TJ, Surratt H, Inciardi JA, Munoz A.

Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):827-40.

PMID:
17636553
20.

Volume of prescription opioids used nonmedically in the United States.

Katz NP, Birnbaum HG, Castor A.

J Pain Palliat Care Pharmacother. 2010 Jun;24(2):141-4. doi: 10.3109/15360281003799098.

PMID:
20504136
Items per page

Supplemental Content

Support Center